ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 15 filers reported holding ACORDA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $9,828,000 | +103.0% | 10,080,000 | +39.4% | 0.10% | +71.9% |
Q4 2020 | $4,842,000 | -7.7% | 7,230,000 | +7.4% | 0.06% | -24.0% |
Q3 2020 | $5,248,000 | -9.9% | 6,730,000 | 0.0% | 0.08% | -46.8% |
Q2 2020 | $5,823,000 | -0.7% | 6,730,000 | 0.0% | 0.14% | -9.6% |
Q1 2020 | $5,862,000 | +967.8% | 6,730,000 | +821.9% | 0.16% | +1200.0% |
Q4 2019 | $549,000 | -95.4% | 730,000 | -95.2% | 0.01% | -94.8% |
Q3 2019 | $11,830,000 | -8.0% | 15,120,000 | 0.0% | 0.23% | +65.7% |
Q2 2019 | $12,861,000 | -3.6% | 15,120,000 | 0.0% | 0.14% | -45.3% |
Q1 2019 | $13,343,000 | +101.6% | 15,120,000 | +89.0% | 0.26% | +96.9% |
Q4 2018 | $6,619,000 | -21.6% | 8,000,000 | -20.0% | 0.13% | +41.3% |
Q3 2018 | $8,440,000 | -35.3% | 10,000,000 | -25.9% | 0.09% | -39.9% |
Q2 2018 | $13,047,000 | -28.2% | 13,500,000 | -32.5% | 0.15% | -20.3% |
Q1 2018 | $18,178,000 | +7.3% | 20,000,000 | 0.0% | 0.19% | -16.5% |
Q4 2017 | $16,938,000 | +25.1% | 20,000,000 | +33.3% | 0.23% | +27.1% |
Q3 2017 | $13,538,000 | -21.1% | 15,000,000 | -25.0% | 0.18% | -23.3% |
Q2 2017 | $17,163,000 | +1.0% | 20,000,000 | 0.0% | 0.24% | +20.4% |
Q1 2017 | $17,000,000 | +11.8% | 20,000,000 | 0.0% | 0.20% | -36.4% |
Q4 2016 | $15,200,000 | -6.7% | 20,000,000 | 0.0% | 0.31% | -23.0% |
Q3 2016 | $16,293,000 | +24.3% | 20,000,000 | +33.3% | 0.40% | +29.9% |
Q2 2016 | $13,111,000 | -26.4% | 15,000,000 | -25.0% | 0.31% | -18.5% |
Q1 2016 | $17,802,000 | -38.1% | 20,000,000 | -20.0% | 0.38% | -26.5% |
Q4 2015 | $28,767,000 | +58.3% | 25,000,000 | +25.0% | 0.51% | +60.1% |
Q3 2015 | $18,167,000 | -27.9% | 20,000,000 | -20.0% | 0.32% | -22.3% |
Q2 2015 | $25,188,000 | -1.2% | 25,000,000 | 0.0% | 0.41% | -23.4% |
Q1 2015 | $25,492,000 | +11.2% | 25,000,000 | +25.0% | 0.54% | +25.6% |
Q4 2014 | $22,932,000 | +38.5% | 20,000,000 | +25.0% | 0.43% | +13.5% |
Q3 2014 | $16,560,000 | – | 16,000,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |